Skip to main content
Livermore
Livermore
ZHEN

Van Eck Associates Corp

SEC CIK
0000869178
Latest filing
Aug 14, 2026

GSK holding history

GSK plc in every 13F filed by Van Eck Associates Corp, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

GSK overviewAll 13F holders of GSKFull Q2 2026 holdings

Shares (Q2 2026)
787,508
Value
$41.3M
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of GSK by Van Eck Associates Corp, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 2026787,508$41.3M<0.1%−279,140−26.2%ReducedHolders
Q1 20261,066,648$58.9M<0.1%−127,719−10.7%ReducedHolders
Q4 20251,194,367$58.6M<0.1%+540,104+82.6%AddedHolders
Q3 2025654,263$28.2M<0.1%−59,590−8.3%ReducedHolders
Q2 2025713,853$27.4M<0.1%−95,812−11.8%ReducedHolders
Q1 2025809,665$31.4M<0.1%−34,374−4.1%ReducedHolders
Q4 2024844,039$28.5M<0.1%+107,529+14.6%AddedHolders
Q3 2024736,510$28.0M<0.1%+56,843+8.4%AddedHolders
Q2 2024679,667$26.2M<0.1%+81,233+13.6%AddedHolders
Q1 2024598,434$25.7M<0.1%+68,846+13.0%AddedHolders
Q4 2023529,588$19.6M<0.1%−56,593−9.7%ReducedHolders
Q3 2023586,181$21.2M<0.1%+67,892+13.1%AddedHolders
Q2 2023518,289$18.5M<0.1%+10,418+2.1%AddedHolders
Q1 2023507,871$18.1M<0.1%−236,042−31.7%ReducedHolders
Q4 2022743,913$26.1M0.1%−74,421−9.1%ReducedHolders
Q3 2022818,334$24.1M0.1%+207,901+34.1%AddedHolders
Q2 2022610,433$26.6M0.1%+219,343+56.1%AddedHolders
Q1 2022391,090$17.0M<0.1%+17,666+4.7%AddedHolders
Q4 2021373,424$16.5M<0.1%+4,292+1.2%AddedHolders
Q3 2021369,132$14.1M<0.1%+100,258+37.3%AddedHolders
Q2 2021268,874$10.7M<0.1%−24,026−8.2%ReducedHolders
Q1 2021292,900$10.5M<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.